Daniel Alfaiate | Medicine | Research Hypothesis Excellence Award

Published on 28/08/202628/08/2026 by Research Hypothesis

Research Hypothesis Excellence Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation	Instituto Politécnico de Castelo Branco
Country	Portugal
Scopus ID	58158006300
Documents	3
Citations	31
h-index	2
Subject Area	Medicine
Event	International Research Hypothesis Excellence Award
ORCID	0000-0002-5581-4242

Daniel Alfaiate the Research Hypothesis Excellence Award recognizes research activity characterized by a clearly defined scientific problem, systematic investigation, and contributions that can inform further study. Daniel Alfaiate is affiliated with the Instituto Politécnico de Castelo Branco in Portugal and has a publication record centered on sleep medicine, obstructive sleep apnea, sleep physiology, electroencephalography, and the effects of medication on sleep architecture. The documented publications provide a basis for assessing the researcher’s alignment with an international research recognition program in medicine.

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

Daniel Alfaiate’s documented research profile is focused on clinical and physiological aspects of sleep and respiratory medicine. His publications examine topics including psychotropic medication and sleep architecture, obstructive sleep apnea and hematological parameters, wakefulness electroencephalography in patients with obstructive sleep apnea, and body posture among patients receiving non-invasive ventilation. These studies collectively address clinically relevant questions involving sleep physiology, respiratory disorders, diagnostic assessment, and treatment-related factors. The available record reports three documents, 31 citations, and an h-index of 2, providing bibliometric context for evaluating the researcher’s scholarly activity.[1] [2]

Keywords

Daniel Alfaiate; sleep medicine; obstructive sleep apnea; sleep architecture; polysomnography; electroencephalography; non-invasive ventilation; respiratory medicine; psychotropic medication; clinical research; medical research; research hypothesis; Portugal.

Introduction

Sleep medicine integrates clinical observation, physiological measurement, diagnostic technologies, and therapeutic evaluation to investigate disorders affecting sleep and breathing. Obstructive sleep apnea is characterized by recurrent episodes of upper-airway obstruction during sleep and can be studied through clinical assessment and objective sleep-related measurements. Research involving polysomnography, electroencephalography, respiratory parameters, and related physiological indicators can therefore contribute to a more detailed understanding of patient characteristics and treatment considerations.[1] [2] [3] [4]

Research Profile

Daniel Alfaiate is affiliated with the Instituto Politécnico de Castelo Branco in Portugal. The supplied bibliometric profile identifies Scopus Author ID 58158006300 and reports three documents, 31 citations, and an h-index of 2. These values represent the supplied research-profile information and should be interpreted in relation to the indexing date and database coverage.

Research Contributions

The research record contains several contributions to the study of sleep and respiratory disorders. A recent article in the European Journal of Pharmacology investigates the class-specific and cumulative effects of psychotropic medication on sleep architecture using polysomnographic retrospective data. This study addresses the relationship between medication exposure and objectively measured sleep characteristics, providing a clinical pharmacology perspective on sleep physiology. [1]

Publications

The supplied publication record includes the following works. DOI identifiers are provided where available and link directly to the corresponding DOI resolution service.

Alfaiate, D.; Silva, P.; Guerra, P.; Pinto, N.; Pereira, A. “Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study.” European Journal of Pharmacology, 2026-08.
Guerra, P.; Alfaiate, D.; Pinto, N.; Pereira, T.; Pereira, A. “Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study.” Sleep and Breathing, 2025.
Pereira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. “Evaluation of wakefulness electroencephalogram in OSA patients.” Research Square, 2024.

Research Impact

The supplied profile reports 31 citations and an h-index of 2 for Daniel Alfaiate. Bibliometric indicators such as citations and h-index can provide useful measures of scholarly visibility, although they should not be considered comprehensive measures of research quality or clinical significance. Citation counts can vary among databases and change over time.

Award Suitability

Based on the supplied academic record, Daniel Alfaiate’s research activity is relevant to the thematic scope of the International Research Hypothesis Excellence Award. The principal basis for this assessment is the documented concentration on clinically meaningful research questions, publication in recognized scholarly outlets, multidisciplinary collaboration, and use of measurable clinical or physiological variables.

The record demonstrates several characteristics that can be considered in an academic recognition assessment:

Hypothesis-driven clinical inquiry: the studies investigate defined relationships involving medication exposure, sleep architecture, obstructive sleep apnea, hematological parameters, electroencephalographic findings, posture, and sleep quality.
Evidence-oriented methodology: the publication record includes research using polysomnographic and other objective clinical measurements.

Conclusion

Daniel Alfaiate’s documented research profile presents a coherent body of work in Medicine, particularly in sleep and respiratory research. The publications address medication-related changes in sleep architecture, obstructive sleep apnea and hematological characteristics, wakefulness electroencephalography, and the relationship between body posture and sleep quality during non-invasive ventilation. [1] [2] [4] [5]

External Links

References

Alfaiate, D.; Silva, P.; Guerra, P.; Pinto, N.; Pereira, A. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
https://doi.org/10.1016/j.ejphar.2026.179292
Guerra, P.; Alfaiate, D.; Pinto, N.; Pereira, T.; Pereira, A. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
https://doi.org/10.1007/s11325-025-03330-2
Pereira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Research Square.
https://doi.org/10.21203/rs.3.rs-3831506/v1
Ferreira, I.; Guerra, P.; Pinto, N.; Alfaiate, D.; Pereira, A. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
https://doi.org/10.1007/s11325-024-03116-y
Alfaiate, D.; Pereira, A.; Guerra, P.; Pinto, N. (2023). Body posture as a factor determining sleep quality in patients using non-invasive ventilation. Sleep and Breathing.
https://doi.org/10.1007/s11325-023-02817-0

Shiji Fang | Medicine | Best Researcher Award

Published on 25/08/202625/08/2026 by Research Hypothesis

Best Researcher Award

Shiji Fang
Lishui Central Hospital, China

Shiji Fang
Affiliation	Lishui Central Hospital
Country	China
Scopus ID	57192204982
Documents	91
Citations	2,574
h-index	27
Subject Area	Medicine
Event	International Research Hypothesis Excellence Award
ORCID	0009-0004-4998-5039

Shiji Fang is a medical researcher affiliated with Lishui Central Hospital in China whose indexed research profile reflects sustained scholarly activity in biomedical and translational medicine. The available Scopus-derived profile records 91 documents, 2,574 citations and an h-index of 27, indicating a substantial body of indexed research and citation activity. [1][2]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

Shiji Fang’s research profile is situated within medicine and includes a substantial body of indexed scholarly work. The supplied publication record highlights research at the intersection of cancer biology, tumor microenvironment, immunotherapy and nanomedicine. Recent studies address mechanisms and therapeutic approaches involving immunogenic cell death, reactive oxygen species, endoplasmic reticulum stress, cellular senescence, copper homeostasis, ferroptosis, cuproptosis, chemoembolization and MRI-guided therapeutic systems. [1] [2]

Keywords

Shiji Fang; Best Researcher Award; Medicine; cancer research; hepatocellular carcinoma; immunotherapy; nanomedicine; immunogenic cell death; ferroptosis; cuproptosis; tumor biology; therapeutic delivery; translational medicine; oxidative stress; endoplasmic reticulum stress.

Introduction

Contemporary cancer research increasingly integrates molecular oncology with materials science, immunology and targeted therapeutic delivery. Hepatocellular carcinoma in particular presents a complex therapeutic environment in which tumor heterogeneity, immune suppression and resistance mechanisms can limit treatment effectiveness. Research that investigates interactions among tumor cells, immune pathways and therapeutic nanoplatforms therefore forms an important component of translational biomedical investigation.[2] [3]

Research Profile

The supplied Scopus profile identifies Shiji Fang with Author ID 57192204982 and lists Lishui Central Hospital, China, as the institutional affiliation. The profile is associated with the subject area of Medicine and records 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Research characteristics

Primary discipline: Medicine.
Institutional affiliation: Lishui Central Hospital, China.
Scopus Author ID: 57192204982.
Indexed documents: 91.
Reported citations: 2,574.
Reported h-index: 27.
Major themes represented: cancer biology, hepatocellular carcinoma, immunotherapy, nanomedicine and regulated cell-death mechanisms.

Research Contributions

The supplied publications indicate several connected areas of research contribution. One strand examines how natural or bioactive compounds can influence cancer-cell death and stress-response pathways. The 2025 article on astragalin investigates immunogenic cell death in liver cancer in connection with NQO2, reactive oxygen species and endoplasmic reticulum stress. [2]

A second strand concerns the integration of cellular senescence with immune activation. The study published in Advanced Science describes a biomimetic nanomedicine approach designed around senescence-modulated immune activation and its potential relationship with immunotherapy efficacy in hepatocellular carcinoma. [3]

Publications

The following selected publications are taken from the supplied Scopus-derived research information. The list emphasizes recent 2025 articles and includes DOI identifiers where provided.

Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
Corrigendum to “Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma”. Cellular Signalling.

Research Impact

The supplied bibliometric indicators provide a quantitative view of the visibility of the research record. With 2,574 reported citations and an h-index of 27 across 91 indexed documents, the profile demonstrates sustained citation activity within the indexed scholarly literature. [1] Bibliometric measures should nevertheless be interpreted alongside publication quality, methodological rigor, authorship contributions and the substantive influence of individual studies.

Award Suitability

The Best Researcher Award within the International Research Hypothesis Excellence Award framework can be assessed using evidence concerning research productivity, scholarly visibility, thematic contribution and relevance to the broader research community. The supplied profile provides several measurable indicators, including 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Conclusion

Shiji Fang’s supplied academic profile presents an established research record in Medicine, with affiliation to Lishui Central Hospital in China and a Scopus Author ID of 57192204982. The reported 91 documents, 2,574 citations and h-index of 27 provide quantitative indicators of scholarly activity and citation visibility. [1]

External Links

References

Elsevier. (n.d.). Scopus author details: Shiji Fang, Author ID 57192204982. Scopus.
https://www.scopus.com/pages/authors/57192204982
Zheng, L., Zhao, Z., Chen, L., Yang, W., Ercolani, G., Qin, P., Lin, B., Han, M., Weng, Q., Zhang, Y., et al. (2025). Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
https://doi.org/10.1016/j.freeradbiomed.2025.07.047
Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025). Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
https://doi.org/10.1002/advs.202517792
Liang, X., Fang, S., Xin, Y., Lei, J., Wang, W., Wei, Y., Li, W., Li, C., Tang, H., Wei, X., et al. (2025). Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
https://doi.org/10.1186/s12951-025-03722-2
Chen, M., Chen, Y., Chen, W., Chen, X., Guo, X., Yu, J., Guo, X., Wang, M., Zhang, X., Hu, Q., et al. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia.
https://doi.org/10.1016/j.actbio.2025.04.042
Chen, X., Zhang, F., Lu, C., Wu, R., Yang, et al. (2025). Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma. ACS Applied Materials and Interfaces.
https://doi.org/10.1021/acsami.4c21890

Xue Li | Medicine and Health Sciences | Research Excellence Award

Published on 03/01/202603/01/2026 by Research Hypothesis

Mrs. Xue Li | Medicine and Health Sciences | Research Excellence Award

Mrs. Xue Li | Medicine and Health Sciences | Associate Professor | Shanghai University | China

Mrs. Xue Li is an Associate Professor in the School of Psychology at Shanghai University of Sport and a recognized scholar in the interdisciplinary domains of sports psychology and women’s mental health. She holds a doctoral degree in psychology from a nationally accredited university, where her academic training emphasized experimental psychology, cognitive assessment, and applied mental health research. Professionally, Mrs. Xue Li has developed a strong academic profile through her teaching, research leadership, and curriculum innovation within higher education, particularly in psychology programs integrating sport science and behavioral health. Her research interests focus on cognitive and emotional regulation in female populations, attention bias, psychological risk assessment, time perception in athletes, and the mental health benefits of structured physical and mind–body interventions such as yoga. Mrs. Xue Li possesses advanced research skills in experimental design, psychological measurement, virtual simulation development, data analysis, and interdisciplinary collaboration, enabling her to translate theoretical models into applied educational and clinical contexts.

View ORCID Profile

Featured Publications

Regular Yoga Modulates Attention Bias During the Luteal Phase in Women with Premenstrual Syndrome

– Brain Sciences, Multidisciplinary Digital Publishing Institute

Claudia Lommatzsch | Medicine and Health Sciences | Visionary Research Award 2971

Published on 23/12/202526/12/2025 by Research Hypothesis

Dr. Claudia Lommatzsch | Medicine and Health Sciences | Visionary Research Award

Dr. Claudia Lommatzsch | Medicine and Health Sciences | Senior Physician | St. Franziskus-Hospital | Germany

Dr. Claudia Lommatzsch is a distinguished clinician-scientist in ophthalmology, recognized for her significant contributions to glaucoma diagnostics, ocular imaging, and translational vision research. She received her medical education from a leading German medical university and later achieved advanced academic qualification through habilitation, reflecting her expertise in independent research and university-level teaching. Professionally, Dr. Claudia Lommatzsch has built a strong career as a senior physician and researcher within a major ophthalmology department, where she seamlessly integrates clinical responsibilities with innovative research activities. Her professional experience spans patient-centered glaucoma care, advanced imaging diagnostics, and interdisciplinary research collaborations that connect clinical ophthalmology with laboratory-based biomarker analysis. Her primary research interests include glaucoma pathophysiology, optical coherence tomography, OCT angiography, vascular and molecular biomarkers, pediatric ocular imaging, and disease progression assessment, with a particular emphasis on improving early diagnosis and personalized treatment strategies. In the middle of her academic career trajectory, she has authored 28 documents, accumulated 316 citations, and achieved an h-index of 8, demonstrating measurable scientific impact and consistent research productivity within indexed international journals.

Citation Metrics (Scopus)

500

400

300

200

100

Citations316

i10index28

h-index8

🟦 Citations 🟥 Documents 🟩 h-index

View scopus Profile
View ORCID Profile

Featured Publications

ET-1, MMPs, ZAG, and APN Link Reduced Ocular Perfusion to Glaucoma

– Biomolecules, Open Access

Assessment of Chronic Degenerative Eye Disease Progression

– Editorial, Open Access

Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award

Published on 18/10/202518/10/2025 by Research Hypothesis

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award | Physician | The Lower Danube University | Romania

Prof. Dr. Gabriela Gurău is an accomplished Romanian medical researcher, clinician, and academic leader with extensive contributions to the fields of clinical laboratory medicine, infectious diseases, and metabolic disorders. She holds a Ph.D. in Medical Sciences from the University of Medicine and Pharmacy “Carol Davila,” Bucharest, complemented by advanced certifications in diabetes, nutrition, metabolic diseases, and laboratory medicine from the Ministry of Health and the Training Center for Doctors and Pharmacists. Currently serving as Professor Habil. at the Faculty of Medicine and Pharmacy, University “Dunarea de Jos” of Galați, she also fulfills the role of Head of the Clinical Laboratory at the Clinical Emergency Hospital for Children “Sfântul Ioan.” Throughout her professional journey, Prof. Dr. Gabriela Gurău has demonstrated exceptional skill in integrating clinical diagnostics with translational research, focusing on pediatric infections, antibiotic resistance, microbiological profiling, and metabolic disorders. Her research interests include pathogen surveillance, microbial resistance mechanisms, pediatric metabolic health, and the interplay between microbiota and systemic diseases. With an active research portfolio, she has participated in numerous national and international projects, including innovative studies funded by PN II, AUF, and institutional grants, contributing significantly to Romania’s biomedical research landscape. She is the author and co-author of impactful peer-reviewed articles published in leading scientific journals indexed in Scopus and Web of Science, such as Life, Viruses, International Journal of Molecular Sciences, Applied Sciences, and Infection and Drug Resistance, reflecting her commitment to scientific excellence and knowledge dissemination. Her strong research skills span molecular diagnostics, laboratory analytics, data interpretation, and interdisciplinary collaboration, all of which reinforce her as a versatile scientist bridging clinical medicine and public health research. Recognized for her scholarly achievements and leadership, Prof. Dr. Gabriela Gurău has been a key figure in organizing medical conferences like MedFarmLab, served as Head of the Department of Morphological and Functional Sciences, and contributed actively to professional societies and research committees. Her dedication has earned her respect as a mentor, educator, and innovator in Romanian academia. Prof. Dr. Gabriela Gurău’s career exemplifies a synthesis of scientific rigor, community service, and academic distinction, underpinned by her mission to improve pediatric healthcare outcomes through evidence-based research. With her established reputation, international collaborations, and evolving leadership roles, Prof. Dr. Gabriela Gurău continues to advance the frontiers of laboratory medicine and inspire emerging generations of biomedical scientists worldwide.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Matache, E. R., Gurău, G., Stoian, V. I., Zaharia, A. E., Ciocoiu, M., Maftei, N. M., & Tutunaru, D. (2025). Bordetella pertussis in children: A retrospective analysis of the clinical impact and the role of vaccination. Life, 15(10), 1514.
Matache, E. R., Gurău, G., Raileanu, C. R., Zaharescu, A., Popa, G. V., Maftei, N. M., & Tutunaru, D. (2025). Pathogen profile of children hospitalised with viral respiratory infections in Galati County, Romania. Viruses, 17(4), 586.
Ursu, M., Cretu-Stuparu, M., Gurău, G., Nitoi, L. C., Nechita, A., & Arbune, M. (2024). An epidemiological perspective on new pediatric cases of type 1 diabetes and vitamin D deficiency in South-East Romania: A retrospective study. Children, 11(10), 1162.
Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Tatu, A. L. (2024). An eastern county from a European eastern country—The characteristics of cutaneous microbiome in psoriasis patients—Preliminary results. Life, 14(6), 678.
Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Popa, L. G. (2024). Comparative analysis of the cutaneous microbiome in psoriasis patients and healthy individuals—Insights into microbial dysbiosis: Final results. International Journal of Molecular Sciences, 25(19), 10583.
Iancu, A. V., Arbune, M., Zaharia, E. A., Tutunaru, D., Maftei, N. M., Peptine, L. D., Tocu, G., & Gurău, G. (2023). Prevalence and antibiotic resistance of Enterococcus spp.: A retrospective study in hospitals of Southeast Romania. Applied Sciences, 13(6), 3866.
Arbune, M., Gurău, G., Niculet, E., Iancu, A. V., Lupasteanu, G., Fotea, S., Vasile, M. C., & Tatu, A. L. (2021). Prevalence of antibiotic resistance of ESKAPE pathogens over five years in an infectious diseases hospital from South-East Romania. Infection and Drug Resistance, 14, 2369–2378.

Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award

Published on 17/10/202517/10/2025 by Research Hypothesis

Dr. Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award

Dr. Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award | Director | King Fahad Specialist Hospital | Saudi Arabia

Dr. Kholoud Alwosaibai is a highly accomplished biomedical scientist, cancer geneticist, and immunotherapy specialist with over fifteen years of progressive experience in translational oncology, molecular medicine, and clinical genomics. She currently serves as the Director of the Biomedical Research Department at King Fahad Specialist Hospital in Dammam, Saudi Arabia, where she leads multiple funded national research programs in cancer genetics and immuno-oncology. Dr. Kholoud Alwosaibai earned her Ph.D. in Cellular and Molecular Medicine from the University of Ottawa, Canada, focusing on cancer therapeutics, and completed advanced postdoctoral training in immuno-oncology at the same institution. Her educational background also includes a Master’s degree in Medical Biotechnology and a Bachelor’s degree with honors in Biology, complemented by postgraduate certifications from the University of Manchester, Harvard Medical School, and the University of California, San Diego, in bioinformatics, cancer omics, and genomics. Professionally, Dr. Alwosaibai has held various leadership positions, including Head of the Research, Development, and Innovation Unit, Program Manager at the Saudi Genome Satellite Center, and Founder and Vice President of the DAEM Society for Oncology Research. Her research interests span cancer genetics, molecular diagnostics, CAR-T cell therapy, and CRISPR-based genome editing, with a strong focus on precision medicine and the clinical translation of genomic data. Dr. Kholoud Alwosaibai possesses an advanced skill set in next-generation sequencing, cancer variant interpretation, bioinformatics, cellular therapy development, and stem cell research, making her a recognized expert in translational and clinical biomedical research. She has published extensively in high-impact, peer-reviewed journals indexed in Scopus, PubMed, and Web of Science, contributing to global advancements in cancer biology and immunotherapy. Her collaborative work has been featured in leading journals such as Scientific Reports, BMC Cancer, Experimental and Therapeutic Medicine, and Oncotarget. Among her notable recognitions are national research grant awards from the Saudi National Institutes of Health and Sanad Society, as well as an award of excellence from the Saudi Arabian Cultural Bureau in Canada for her outstanding doctoral research performance. Throughout her career, Dr. Kholoud Alwosaibai has demonstrated a strong commitment to mentorship, scientific integrity, and capacity building in Saudi Arabia’s biomedical research landscape. Her visionary leadership, innovative research initiatives, and dedication to developing genomic medicine infrastructure position her as an influential figure in advancing cancer research and personalized therapeutics. In conclusion, Dr. Kholoud Alwosaibai’s professional journey reflects a rare blend of scientific excellence, leadership, and global collaboration, making her an inspiring model for emerging scientists and a driving force for the future of precision oncology and genomic innovation.

Profile: Scopus | ORCID

Featured Publications

Alwosaibai, K., Abedini, A., Al-Hujaily, E. M., Tang, Y., Garson, K., Collins, O., & Vanderhyden, B. C. (2017). PAX2 maintains the differentiation of oviductal epithelium and inhibits the transition to a stem cell-like state. Oncotarget. Citations: 85
Gharaibeh, L., Elmadany, N., Alwosaibai, K., & Alshaer, W. (2020). Notch 1 in cancer therapy: Possible clinical implications and challenges. Molecular Pharmacology. Citations: 64
Ghandorah, S., & Alwosaibai, K. (2021). Post-liver transplantation GVHD: Time to consider histocompatibility testing. Journal of Liver Transplantation. Citations: 22
Alwosaibai, K., Al-Hujaily, E. M., Alamri, S., Ghandorah, S., Garson, K., & Vanderhyden, B. C. (2022). PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer. Experimental and Therapeutic Medicine, 23(6), 412. Citations: 37
Alwosaibai, K., Aalmri, S., Mashhour, M., Ghandorah, S., Alshangiti, A., Azam, F., Selwi, W., Gharaibeh, L., Alatawi, Y., Alruwaii, Z., & Alsaab, H. O. (2023). PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers. BMC Cancer, 23(1), 13. Citations: 41
Alessy, S. A., Almotlak, A. A., Alattas, M., Alshareef, A., Alwosaibai, K., Alghamdi, M. A., Razack, H. I. A., & Alqahtani, S. A. (2024). Cancer research challenges and potential solutions in Saudi Arabia: A qualitative discussion group study. JCO Global Oncology, 10, e2300189. Citations: 18
Alwosaibai, K., Alruwaii, Z. I., Mashhour, M., Almsned, F. M., Asraf, R., Alrsheedy, W., Alessa, A., Almohanna, H., Selwi, W., & Azam, F. (2024). Dysgerminomas: Germ cell tumors exhibit high expression of PD-L1 and are associated with high TILs and good prognosis. Scientific Reports, 14(1), 24191. Citations: 12

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Published on 03/05/202503/05/2025 by Research Hypothesis

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Prof Jim Sheu, National Sun Yatsen University, Taiwan

Prof. Jim Sheu is a distinguished biomedical scientist with over two decades of academic and research excellence in life sciences. Holding a Ph.D. in Life Science from National Tsing-Hua University (2002), he has consistently advanced the frontiers of molecular oncology, stem cell therapy, and women’s reproductive health. Currently a professor at National Sun Yat-sen University, Taiwan, he has previously held prestigious research and academic positions at China Medical University and Johns Hopkins Medical Institutions. He is widely recognized for his role in leading innovative biomedical projects and mentoring the next generation of scientists. Prof. Sheu has made pioneering contributions to cancer genomics, glioblastoma therapeutics, and endometriosis research. His prolific publication record and multiple awards underline his leadership and innovation in the field. His work bridges translational research with clinical applications, shaping modern therapeutic strategies.

Publication Profile

Google Scholar

Education

Prof. Jim Sheu’s educational journey laid a strong foundation for his impactful scientific career. He earned his Ph.D. in Life Science from the prestigious National Tsing-Hua University, Taiwan, in 2002 🧬. This doctoral training provided him with deep expertise in molecular biology, genetics, and biomedical research. Prior to that, he completed his B.S. in Biology from Fu-Jen University, Taiwan, in 1994 🧪. The rigorous academic environment at these institutions honed his critical thinking and experimental skills. His thesis and postdoctoral work involved advanced molecular techniques and translational research applications. With education deeply rooted in cellular biology and medical biotechnology, Prof. Sheu has seamlessly integrated his academic background with real-world research, evolving into a leading expert in cancer biology, stem cell therapies, and women’s health. His academic excellence has continued to inspire his students and collaborators across various institutes.

Experience

Prof. Sheu’s career spans academia, clinical research, and biotechnology. Since 2014, he has served as Professor at the Institute of Biomedical Sciences, National Sun Yat-sen University 🏫. Previously, he held multiple roles at China Medical University (2006–2014), including Researcher, Professor, Associate Professor, and Assistant Professor in the Graduate Institute of Chinese Medical Science 🧑‍🏫. His early international experience includes being a Research Fellow at Johns Hopkins Medical Institutions (2004–2006) 🔬. He also held leadership positions at Taiwan’s Development Center for Biotechnology (2003–2004), directing and managing key protein drug and biomedicine projects. His academic and research trajectory is marked by interdisciplinary innovation, integrating biomedical engineering, genetics, and pharmacology. Prof. Sheu’s deep involvement in translational research and collaborative initiatives underpins his reputation as a scientific leader in Taiwan and beyond.

Awards & Honors

Prof. Sheu has earned several prestigious honors celebrating his research excellence and innovation. In 2023, he was part of the award-winning Biomedical Team at National Sun Yat-sen University for a serum-free stem cell medium at the NBRP Pitch Day 🧫🏅. He also received the Outstanding Faculty of Basic Research award and the Tien-Te Lee Award for an outstanding poster on stem cell therapies for Parkinson’s disease. In 2022, he was honored by the Taiwan Endometriosis Society for his research using traditional medicine to modulate immune responses 🌿🧠. Additionally, he won the Prof. Chii-Ruey Tzeng Award for an impactful paper in endometriosis research. These accolades highlight Prof. Sheu’s interdisciplinary impact, bridging traditional Chinese medicine, molecular biology, and cutting-edge therapeutic development. His continuous recognition by scientific communities underscores his leadership in biomedical innovation.

Research Projects

Prof. Jim Sheu has actively contributed as a project reviewer in the field of life sciences since 2012 🌱. He serves the National Science and Technology Council (NSTC) in Taiwan and has reviewed projects for various institutions including Tri-Service General Hospital (2021–present), Kaohsiung Veterans General Hospital (2021–present), and Zuoying Armed Forces General Hospital (2020–present) 🏥. He also evaluated projects for National Tsing-Hua University (2023) and Kaohsiung Chang Gung Smart Hospital (2022) 🎓. His expertise has extended globally, reviewing for Italy’s Ministry of Health in 2015 🇮🇹 and South Africa’s Medical Research Council in 2012 🇿🇦, showcasing his international recognition 🌍.

Research Focus

Prof. Sheu’s research is centered on cancer biology, stem cell therapy, gynecological diseases, and translational medicine. He explores the molecular mechanisms of tumor progression, particularly in microsatellite instability and glioblastoma 🔍🧠. His investigations into ethnic-specific genetic markers for endometriosis and ovarian aging highlight his commitment to personalized medicine. Another focus lies in the regulation of immune responses using traditional herbal compounds, bridging modern molecular science with Eastern medicine 🌿🧪. He has led multi-omics studies that decode complex disease pathways, including mitochondrial dysfunction in breast cancer. Additionally, he is advancing serum-free stem cell enhancement technologies aimed at clinical application. Prof. Sheu’s interdisciplinary approach links genomics, proteomics, and pharmacology, translating basic research into viable therapeutic strategies. His work significantly contributes to understanding cellular aging, reproductive biology, and cancer therapy.

Publication Top Notes

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells

Autophagy and its link to type II diabetes mellitus

Talin‐1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Published on 11/12/202411/12/2024 by Research Hypothesis

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yasser Khazaal, Lausanne university, Switzerland

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist and researcher with extensive experience in addiction psychiatry. He earned his MD from René Descartes, Paris V, and Swiss Board Certification in Psychiatry and Psychotherapy. Currently, he is a Full Professor at the University of Lausanne, Switzerland, and holds multiple roles including Associate Researcher at Montreal University. Prof. Khazaal’s research focuses on cognitive behavioral therapies, game-based interventions, and the development of smartphone apps for addiction treatment. He has published extensively on addictive disorders and is a key figure in international psychiatric societies. 🏥📚🔬

Publication Profile

google scholar

Education

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist with an impressive academic background. He earned his MD from René Descartes, Paris V, France, in 1998. In 2005, he achieved Swiss Board Certification in Psychiatry and Psychotherapy. His expertise and contributions were further recognized with his appointment as a Privat Docent (senior lecturer) at Geneva University in 2009. Dr. Khazaal is known for his work in psychiatry and psychotherapy, holding a prominent position in the academic and clinical communities in Switzerland. 🌐🩺📚

Employment History

Prof. Dr. Yasser Khazaal has an extensive background in addiction psychiatry. From 2003 to 2005, he served as a senior psychiatrist and head of the mood and anxiety disorders outpatient unit at Lausanne University Hospital. From 2007 to 2018, he was the deputy head of the Addiction clinic at Geneva University Hospitals. Over the years, he held successive academic appointments at Geneva University, Switzerland, eventually becoming a full professor of addiction psychiatry at the Faculty of Biology and Medicine, University of Lausanne since 2019. He is also a member of the board of Addiction medicine at Lausanne University Hospital. Prof. Khazaal is an associate researcher at the Montreal University Institute of Mental Health, Canada, and an associate professor at the Department of Psychiatry and Addiction, Montreal University, Canada. Additionally, he served as a visiting professor at Kazimierz Wielki University, Poland, in 2022, as part of a project co-financed by the European Union. 📘🔍🌍

Teaching

Prof. Dr. Yasser Khazaal has extensive experience in teaching medical students at both the University of Lausanne (2003-2007, 2019-2023) and the University of Geneva (2007-2018). His teaching portfolio includes courses on mood and anxiety disorders (2003-2007), psychopharmacology (2006-2007), addiction (2019-2023), and community research in practice (2021-2023). He has also taught and supervised clinical cognitive and behavior therapy (CBT) skills (2018-2023), CBT for bipolar disorder (2007), CBT for mood disorders (2005-2006), and CBT of impulsive behaviors (2020). Prof. Dr. Khazaal is committed to integrating clinical teaching and practice in his courses. 📚💬🧠

Grants

Prof. Dr. Yasser Khazaal is a leading researcher in addiction and mental health, with extensive funding from various Swiss and international sources. His projects include studies on cognitive behavioral interventions for psychosis, mood and anxiety disorders, smoking cessation, and smartphone applications for addiction treatment. Key grants include the Swiss National Science Foundation (268,426 CHF) and Astra-Zeneca (140,000 CHF) for LACOSMA, as well as research on “Impact of Pick Klop game on smoking cessation” (172,500 CHF) and smartphone applications (194,942 CHF). He collaborates internationally on projects such as managing trauma exposure in Congo (12,125 Euros) and the “Sesame” serious game for mental health (20,000 CHF). His work continues to advance the field with a focus on innovative and practical solutions to addiction and mental health challenges. 🧠💊🚬

Conferences and Awards

Prof. Dr. Yasser Khazaal is a distinguished academic and leader in the field of social psychiatry. He served as the Chair for the European Congress of Social Psychiatry in 2012, 2015, and 2018. He was also the Co-chair for the International Conference of Behavioral Addictions in 2016, held in Geneva, Switzerland. More recently, he co-chaired the Challenges of Ecology Related to Mental Health conference in Athens in 2022. In recognition of his contributions, he was elected an Honorary Fellow of the World Association of Social Psychiatry in 2013. 🌍🔍💬

Scientific Achievements

Prof. Dr. Yasser Khazaal is a renowned expert in addiction studies, focusing on game-based interventions, including delusions and smoking cessation. He has contributed significantly to the development of smartphone app interventions for addictive disorders and mood regulation. Prof. Khazaal has published extensively on the assessment and psychopathology of addictive disorders. He also leads research on Recovery Oriented Services, exploring community interventions and peer support initiatives. 🌱📱🚭📚

Research Focus

Yasser Khazaal is a researcher primarily focused on behavioral addictions, particularly in the context of online gaming and internet use. His work explores how common behaviors can become problematic without necessarily being pathologized as addiction. He investigates self-reported motivations behind playing online games, such as World of Warcraft, and examines problematic involvement in these games using various psychological and survey methods. Khazaal’s research aims to refine the understanding of behavioral addiction and its implications for mental health, with a particular interest in the validation and adaptation of assessment tools for addictive behaviors in digital environments. 💻🕹️📊

Publication Top notes

Are we overpathologizing everyday life? A tenable blueprint for behavioral addiction research

How can we conceptualize behavioural addiction without pathologizing common behaviours?

Why do you play World of Warcraft? An in-depth exploration of self-reported motivations to play online and in-game behaviours in the virtual world of Azeroth

French validation of the internet addiction test

Validation of a short French version of the UPPS-P Impulsive Behavior Scale

Problematic involvement in online games: A cluster analytic approach

Does self-selection affect samples’ representativeness in online surveys? An investigation in online video game research

Motivations to play specifically predict excessive involvement in massively multiplayer online role-playing games: evidence from an online survey

semih güler | Medicine and Health Sciences | Best Researcher Award

Published on 07/12/202407/12/2024 by Research Hypothesis

semih güler | Medicine and Health Sciences | Best Researcher Award

Mr semih güler, Sivas Numune Hospital, Turkey

Semih Güler 🎓👂 | Born in Sivas (1996), Semih Güler is a dedicated Master Audiologist passionate about advancing the science of audiology and its humanitarian impact. With top honors in his academic journey, including his Master’s from Cappadocia University, he has over five years of experience in diagnosing and treating hearing and balance disorders at Sivas Numune Hospital. Semih has contributed to academia as a lecturer at Cumhuriyet University and published impactful research on anesthesia’s effects on newborn hearing screening. A licensed football player and Turkish Art Music artist, he thrives on discipline, innovation, and mentoring future audiologists. ⚕️🎼⚽

Publication Profile

Orcid

Education and Qualifications

Semih Güler is an accomplished audiologist with a strong academic background. 🌟 He graduated as the top student 🎓 from Serik Anatolian Health Vocational High School Anesthesia and Reanimation Department (2010–2014) with a 92.12/100 score. 📚 He earned an Associate Degree in Audiometry from Ege University (2015–2016) with a stellar 3.86/4 GPA, ranking first. 🏅 Continuing his excellence, he completed a Bachelor’s in Audiology at Üsküdar University (2016–2018) with High Honors (3.62/4). 🎖️ Semih further earned a Master’s in Audiology from Kapadokya University (2019–2021), achieving a perfect 4.0/4 GPA and ranking first in his department and school. 🥇🎓

Experience

Semih Güler is a dedicated audiology professional with a rich career spanning various roles. He began as an Anesthesia Technician at Antalya Yaşam Hospital (2014), leaving to pursue his education 🎓. As an Intern Audiometrist, he trained at Ege University (2014-2016) and later served as an Intern Audiologist at Üsküdar University (2016-2018). Semih currently specializes in Hearing and Balance Disorders at Sivas Numune Hospital, where he has excelled for over five years 👂💡. He also contributed to education as a Lecturer at Cumhuriyet University (2022-2023) and supported individuals with hearing impairments at Yaşam Special Education Center (2018-2020) 📚🤝.

Professional Growth

Semih Güler’s research focus centers on advanced audiology and vestibular studies. With a strong commitment to self-improvement, he has completed numerous advanced training programs and certifications in these fields. His research explores topics such as hearing disorders, balance issues, and the impact of vestibular dysfunction on quality of life. He aims to contribute to the development of innovative diagnostic and therapeutic techniques to improve patient care and outcomes in audiology and vestibular health. 📡🧠🔍

Courses

Semih Güler has a rich background in audiology, vestibular systems, and emergency life support. 🌍🚑 His journey includes an internship in Bucharest, Romania (2013), with Romanian language training. He has completed numerous specialized trainings such as Newborn Hearing Screening 👶👂, Electrophysiology 🎛️, and Vestibular Evaluation 🎯. Semih has participated in national congresses and seminars, enhancing his expertise in audiology innovations and occupational health and safety 🩺. Notable certifications include Clinical v-HIT and f-HIT applications, wideband tympanometry, and vestibular migraine assessment 🎓. Dedicated to professional growth, Semih contributes to hearing and balance science while aligning with European and Turkish standards. ✨

Achievements

Mr. Semih Güler has excelled in his academic journey, achieving remarkable milestones 🎓🌟. He graduated first in his class from Serik Anatolian Health Vocational High School’s Anesthesia and Reanimation Department 🏅 and Ege University’s Atatürk Health Services Vocational School Audiometry Program 🥇. As a high-honor student at Üsküdar University’s Faculty of Health Sciences in Audiology 📘, he continued to shine academically. His dedication culminated in earning a Master’s Degree in Audiology with a thesis from Cappadocia University’s Graduate Education and Research Institute, where he also ranked first in his department 🥇📜. His achievements reflect his dedication and excellence! 🌟👏

Research Focus

Semih Güler’s research focuses on the effects of delivery type and anesthesia method on Auditory Brainstem Response (ABR) results in newborns. His study, published in the International Journal of Pediatric Otorhinolaryngology, investigates how different delivery methods and anesthesia impact ABR outcomes, which are crucial for newborn hearing screening. The aim is to understand how these factors influence auditory health at an early stage, contributing valuable insights for clinical practices and guidelines in neonatal care. 🌟🎧🔬

Publication Top notes

Effect of type of delivery and anesthesia method to ABR results on Newborn Hearing Screening

Barbara Boucher | Medical Hypotheses | Medical Hypothesis Award

Published on 05/10/202405/10/2024 by Research Hypothesis

Barbara Boucher | Medical Hypotheses | Medical Hypothesis Award

Dr Barbara Boucher Queen Mary University of London United Kingdom

Based on Dr. Barbara Boucher’s extensive background and research, she appears to be a suitable candidate for the Medical Hypothesis Award for several reasons:

Publication profile

Orcid

Comprehensive Medical Training: Dr. Boucher’s foundation in medicine, complemented by an intercalated BSc, reflects a strong academic and clinical background essential for advancing medical research.
Diverse Clinical Experience: Her role as a joint NHS consultant and academic physician showcases her capability in both patient care and teaching. Leading an acute and specialist care team demonstrates her leadership and commitment to improving health services.
Innovative Teaching and Mentorship: Dr. Boucher’s dedication to bedside teaching, tutoring, and formal education in diabetes, endocrinology, and clinical biochemistry indicates her passion for mentoring the next generation of medical professionals.
Development of Specialized Services: She has successfully established a radio-immunoassay laboratory and has contributed to innovative diabetes care programs, reflecting her ability to implement effective healthcare solutions.
Continued Research Focus: Dr. Boucher’s commitment to research, even during clinical retirement, underscores her dedication to advancing medical knowledge. Her work primarily on vitamin D and the non-cancerous effects of betel-chewing illustrates her interest in impactful public health issues.
Peer-Reviewed Publications: Her extensive publication record in reputable journals, such as Nutrients and Biomedicines, demonstrates her contributions to the scientific community. The articles address critical health issues, including vitamin D deficiency and its health implications, which are significant for public health policy and medical practice.
Collaborative Research: Her collaborative efforts with colleagues locally and internationally enhance the relevance and application of her research, contributing to a broader understanding of health impacts on diverse populations.

Suggested Hypothesis for Consideration

Given her research on vitamin D and its implications for various health outcomes, a potential hypothesis she might explore could be:

“Investigating the Role of Vitamin D in Modulating Health Outcomes Among Diverse Populations: A Comprehensive Study on Serum Levels and Associated Health Risks.”

This hypothesis aligns with her research interests and has the potential to impact public health significantly, making her a strong candidate for the Medical Hypothesis Award.